EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.70 | (1E)-N'-[(1E)-(4-[(E)-[(diaminomethylene)hydrazono]methyl]phenyl)methylene]ethanehydrazonamide | - |
Staphylococcus aureus | |
3.4.22.70 | (2E)-2-(2-furoyl)-3-[(methyl[4-[(5-nitropyridin-2-yl)oxy]phenyl]oxido-l4-sulfanylidene)amino]acrylonitrile | - |
Staphylococcus aureus | |
3.4.22.70 | (2E)-3-(2-furyl)-N-[3-(hydroxymethyl)-4-morpholin-4-ylphenyl]acrylamide | - |
Staphylococcus aureus | |
3.4.22.70 | (2E)-3-[(methyl[4-[(5-nitropyridin-2-yl)oxy]phenyl]oxido-l4-sulfanylidene)amino]-2-(2-thienylcarbonyl)acrylonitrile | - |
Staphylococcus aureus | |
3.4.22.70 | (2E)-4-([4-[(2-hydroxybenzoyl)amino]phenyl]amino)-4-oxobut-2-enoic acid | - |
Staphylococcus aureus | |
3.4.22.70 | (2E)-N-(3-formyl-4-morpholin-4-ylphenyl)-3-(2-furyl)acrylamide | - |
Staphylococcus aureus | |
3.4.22.70 | (2E)-N-(3-formyl-4-morpholin-4-ylphenyl)-3-(2-thienyl)acrylamide | - |
Staphylococcus aureus | |
3.4.22.70 | (2E)-N-[3-(hydroxymethyl)-4-morpholin-4-ylphenyl]-3-(2-thienyl)acrylamide | - |
Staphylococcus aureus | |
3.4.22.70 | 1-[4-(2-aminopyrimidin-4-yl)phenyl]-3-(4-chlorophenyl)urea | - |
Staphylococcus aureus | |
3.4.22.70 | 2-hydroxy-N-[4-[([[(4-methylphenyl)sulfonyl]amino]carbonyl)amino]phenyl]benzamide | - |
Staphylococcus aureus | |
3.4.22.70 | 2-morpholin-4-yl-5-[[(2E)-3-(2-thienyl)prop-2-enoyl]amino]benzamide | - |
Staphylococcus aureus | |
3.4.22.70 | 3,5-bis[[2-(4-nitrophenyl)-2-oxoethyl]thio]isothiazole-4-carbonitrile | - |
Staphylococcus aureus | |
3.4.22.70 | 5-[[(2E)-3-(2-furyl)prop-2-enoyl]amino]-2-morpholin-4-ylbenzoic acid | - |
Staphylococcus aureus | |
3.4.22.70 | methyl 2-morpholin-4-yl-5-[[(2E)-3-(2-thienyl)prop-2-enoyl]amino]benzoate | - |
Staphylococcus aureus | |
3.4.22.70 | methyl 5-[[(2E)-3-(2-furyl)prop-2-enoyl]amino]-2-morpholin-4-ylbenzoate | - |
Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.22.70 | Staphylococcus aureus | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.22.70 | [4-(4-dimethylaminophenylazo)benzoic acid]-QALPETGEE-[5-[2'-(aminoethyl)amino]-naphthalenesulfonic acid] + H2O | - |
Staphylococcus aureus | ? | - |
? |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.4.22.70 | 0.058 | - |
- |
Staphylococcus aureus | methyl 5-[[(2E)-3-(2-furyl)prop-2-enoyl]amino]-2-morpholin-4-ylbenzoate | |
3.4.22.70 | 0.071 | - |
- |
Staphylococcus aureus | methyl 2-morpholin-4-yl-5-[[(2E)-3-(2-thienyl)prop-2-enoyl]amino]benzoate | |
3.4.22.70 | 0.073 | - |
- |
Staphylococcus aureus | (2E)-N-[3-(hydroxymethyl)-4-morpholin-4-ylphenyl]-3-(2-thienyl)acrylamide | |
3.4.22.70 | 0.077 | - |
- |
Staphylococcus aureus | (2E)-N-(3-formyl-4-morpholin-4-ylphenyl)-3-(2-thienyl)acrylamide | |
3.4.22.70 | 0.0973 | - |
- |
Staphylococcus aureus | 3,5-bis[[2-(4-nitrophenyl)-2-oxoethyl]thio]isothiazole-4-carbonitrile | |
3.4.22.70 | 0.105 | - |
- |
Staphylococcus aureus | 2-morpholin-4-yl-5-[[(2E)-3-(2-thienyl)prop-2-enoyl]amino]benzamide | |
3.4.22.70 | 0.107 | - |
- |
Staphylococcus aureus | (2E)-N-(3-formyl-4-morpholin-4-ylphenyl)-3-(2-furyl)acrylamide | |
3.4.22.70 | 0.111 | - |
- |
Staphylococcus aureus | (2E)-3-(2-furyl)-N-[3-(hydroxymethyl)-4-morpholin-4-ylphenyl]acrylamide | |
3.4.22.70 | 0.125 | - |
- |
Staphylococcus aureus | (2E)-4-([4-[(2-hydroxybenzoyl)amino]phenyl]amino)-4-oxobut-2-enoic acid | |
3.4.22.70 | 0.15 | - |
- |
Staphylococcus aureus | (2E)-2-(2-furoyl)-3-[(methyl[4-[(5-nitropyridin-2-yl)oxy]phenyl]oxido-l4-sulfanylidene)amino]acrylonitrile | |
3.4.22.70 | 0.181 | - |
- |
Staphylococcus aureus | 5-[[(2E)-3-(2-furyl)prop-2-enoyl]amino]-2-morpholin-4-ylbenzoic acid | |
3.4.22.70 | 0.226 | - |
- |
Staphylococcus aureus | 2-hydroxy-N-[4-[([[(4-methylphenyl)sulfonyl]amino]carbonyl)amino]phenyl]benzamide | |
3.4.22.70 | 0.275 | - |
- |
Staphylococcus aureus | (1E)-N'-[(1E)-(4-[(E)-[(diaminomethylene)hydrazono]methyl]phenyl)methylene]ethanehydrazonamide | |
3.4.22.70 | 0.4 | - |
- |
Staphylococcus aureus | (2E)-3-[(methyl[4-[(5-nitropyridin-2-yl)oxy]phenyl]oxido-l4-sulfanylidene)amino]-2-(2-thienylcarbonyl)acrylonitrile | |
3.4.22.70 | 0.4 | - |
- |
Staphylococcus aureus | 1-[4-(2-aminopyrimidin-4-yl)phenyl]-3-(4-chlorophenyl)urea |